SCHEMBL23051973

SCHEMBL23051973

CC(=O)N[C@@H](COC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRN P28799 1/20 0.39
▸ SORT1 Q99523 1/20 0.39
▸ MAPK1 P28482 1/20 0.36
▸ MAPT P10636 3/20 0.36
▸ RECQL P46063 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ TDP1 Q9NUW8 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CTSK P43235 6/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29750396 0.84 CAD (0.39) GRNSORT1MAPK1MAPTRECQL
SCHEMBL23051872 0.83 CTSK (0.38) GRNSORT1MAPK1MAPTRECQL
SCHEMBL23051981 0.83 GRN (0.40) GRNSORT1MAPK1TDP1POLB
SCHEMBL29397600 0.81 GRN (0.55) GRNSORT1MAPK1MAPTRECQL
SCHEMBL17513728 0.81 GRN (0.55) GRNSORT1MAPK1MAPTRECQL
SCHEMBL9725956 0.81 GRN (0.55) GRNSORT1MAPK1MAPTRECQL
SCHEMBL20571234 0.81 GRN (0.40) GRNSORT1MAPK1MAPTRECQL
SCHEMBL20571233 0.81 GRN (0.40) GRNSORT1MAPK1MAPTRECQL
SCHEMBL30030351 0.80 CTSS (0.37) GRNSORT1MAPK1MAPTRECQL
SCHEMBL22262968 0.80 MAPK1 (0.38) GRNSORT1MAPK1MAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021038426-A1 SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-03-04 — — WO disclosed
Send feedback